Cargando…

The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period

OBJECTIVES: In this retrospective study, we present a clinical review of our experience with tongue cancer in order to obtain valid criteria for therapeutic decision-making. MATERIALS AND METHODS: Between 1980 and 2009, a total of 341 patients with squamous cell carcinoma of the tongue were treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokemueller, Horst, Rana, Majeed, Rublack, Jennifer, Eckardt, Andre, Tavassol, Frank, Schumann, Paul, Lindhorst, Daniel, Ruecker, Martin, Gellrich, Nils-Claudius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123311/
https://www.ncbi.nlm.nih.gov/pubmed/21600000
http://dx.doi.org/10.1186/1758-3284-3-27
_version_ 1782206967333257216
author Kokemueller, Horst
Rana, Majeed
Rublack, Jennifer
Eckardt, Andre
Tavassol, Frank
Schumann, Paul
Lindhorst, Daniel
Ruecker, Martin
Gellrich, Nils-Claudius
author_facet Kokemueller, Horst
Rana, Majeed
Rublack, Jennifer
Eckardt, Andre
Tavassol, Frank
Schumann, Paul
Lindhorst, Daniel
Ruecker, Martin
Gellrich, Nils-Claudius
author_sort Kokemueller, Horst
collection PubMed
description OBJECTIVES: In this retrospective study, we present a clinical review of our experience with tongue cancer in order to obtain valid criteria for therapeutic decision-making. MATERIALS AND METHODS: Between 1980 and 2009, a total of 341 patients with squamous cell carcinoma of the tongue were treated at our Department. The average follow-up was 5.2 years. 309 patients received surgical treatment, which was combined in nearly 10% with neoadjuvant and in nearly 20% with postoperative radio(chemo)therapy. 32 patients were excluded from surgery and received primary radiation. RESULTS: Local and regional failure occurred in 23.9% and 20.4%, leading to a total failure rate of 37.2% after an average duration of 1,6 years. N-Status, extracapsular spread and clear margins were identified as the dominant factors for survival, which was calculated with 54.5% after 5 years. CONCLUSIONS: We recommend categorical bilateral neck dissection in order to reliably remove occult lymph node metastases. Adjuvant treatment modalities should be applied more frequently in controlled clinical trials and should generally be implemented in cases with unclear margins and lymphatic spread. CLINICAL RELEVANCE: This study provides new treatment strategies for primary tumour disease and for tumour recurrence.
format Online
Article
Text
id pubmed-3123311
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31233112011-06-25 The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period Kokemueller, Horst Rana, Majeed Rublack, Jennifer Eckardt, Andre Tavassol, Frank Schumann, Paul Lindhorst, Daniel Ruecker, Martin Gellrich, Nils-Claudius Head Neck Oncol Research OBJECTIVES: In this retrospective study, we present a clinical review of our experience with tongue cancer in order to obtain valid criteria for therapeutic decision-making. MATERIALS AND METHODS: Between 1980 and 2009, a total of 341 patients with squamous cell carcinoma of the tongue were treated at our Department. The average follow-up was 5.2 years. 309 patients received surgical treatment, which was combined in nearly 10% with neoadjuvant and in nearly 20% with postoperative radio(chemo)therapy. 32 patients were excluded from surgery and received primary radiation. RESULTS: Local and regional failure occurred in 23.9% and 20.4%, leading to a total failure rate of 37.2% after an average duration of 1,6 years. N-Status, extracapsular spread and clear margins were identified as the dominant factors for survival, which was calculated with 54.5% after 5 years. CONCLUSIONS: We recommend categorical bilateral neck dissection in order to reliably remove occult lymph node metastases. Adjuvant treatment modalities should be applied more frequently in controlled clinical trials and should generally be implemented in cases with unclear margins and lymphatic spread. CLINICAL RELEVANCE: This study provides new treatment strategies for primary tumour disease and for tumour recurrence. BioMed Central 2011-05-21 /pmc/articles/PMC3123311/ /pubmed/21600000 http://dx.doi.org/10.1186/1758-3284-3-27 Text en Copyright ©2011 Kokemueller et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Kokemueller, Horst
Rana, Majeed
Rublack, Jennifer
Eckardt, Andre
Tavassol, Frank
Schumann, Paul
Lindhorst, Daniel
Ruecker, Martin
Gellrich, Nils-Claudius
The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period
title The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period
title_full The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period
title_fullStr The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period
title_full_unstemmed The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period
title_short The Hannover experience: Surgical treatment of tongue cancer - A clinical retrospective evaluation over a 30 years period
title_sort hannover experience: surgical treatment of tongue cancer - a clinical retrospective evaluation over a 30 years period
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123311/
https://www.ncbi.nlm.nih.gov/pubmed/21600000
http://dx.doi.org/10.1186/1758-3284-3-27
work_keys_str_mv AT kokemuellerhorst thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT ranamajeed thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT rublackjennifer thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT eckardtandre thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT tavassolfrank thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT schumannpaul thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT lindhorstdaniel thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT rueckermartin thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT gellrichnilsclaudius thehannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT kokemuellerhorst hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT ranamajeed hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT rublackjennifer hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT eckardtandre hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT tavassolfrank hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT schumannpaul hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT lindhorstdaniel hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT rueckermartin hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod
AT gellrichnilsclaudius hannoverexperiencesurgicaltreatmentoftonguecanceraclinicalretrospectiveevaluationovera30yearsperiod